Maternal Gestational Diabetes Mellitus Linked to Elevated Risk of Atopic Dermatitis in Offspring: Insights from a National Retrospective Cohort Study Analyzing Treatment Approaches - Scorecard - MDSpire

Maternal Gestational Diabetes Mellitus Linked to Elevated Risk of Atopic Dermatitis in Offspring: Insights from a National Retrospective Cohort Study Analyzing Treatment Approaches

  • By

  • Sarah Weissmann

  • Nir Amitai

  • Eliya Honig

  • Tamar Eshkoli

  • Amir Horev

  • April 13, 2026

Share

Clinical Scorecard: Maternal Gestational Diabetes Mellitus Linked to Elevated Risk of Atopic Dermatitis in Offspring: Insights from a National Retrospective Cohort Study Analyzing Treatment Approaches

At a Glance

CategoryDetail
Condition
Key MechanismsImpaired skin barrier and type 2 inflammatory response linked to maternal gestational diabetes mellitus (GDM) and its impact on offspring.
Target Population
Care Setting

Key Highlights

  • highlight_1
  • highlight_2

Guideline-Based Recommendations

Diagnosis

    Management

    • Monitor maternal GDM and associated factors during pregnancy, including dietary modifications and glycemic control.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Mothers with gestational diabetes mellitus and their offspring.

        No significant association found between pharmacologic treatment of GDM and AD risk.

        Clinical Best Practices

        • Assess maternal history of allergies and metabolic conditions during prenatal care, supported by recent studies linking these factors to AD.

        Related Resources & Content

        Original Source(s)

        Related Content